[Translated article] Comparing the Use of Topical Therapy Along with Anti-IL-17 and Anti-IL-23 to Treat Moderate-to-Severe Psoriasis in the Routine Clinical Practice S. Berenguer-Ruiz; M. Romero-Dávila; M. Aparicio-Domínguez; M. Olivares-Guerrero; E. Daudén; M. Llamas-Velasco;

Comparación del uso de la terapia tópica combinada con anti-interleucina-17 y anti-interleucina-23 en la psoriasis moderada grave en la práctica clínica S. Berenguer-Ruiz; M. Romero-Dávila; M. Aparicio-Domínguez; M. Olivares-Guerrero; E. Daudén; M. Llamas-Velasco;

Psoriasis Severity, Health-Related Quality of Life, Work Productivity, and Activity Impairments Among Patients With Moderate to Severe Psoriasis Receiving Systemic Treatment: Real-World Data From Clinical Practice in Spain E. Daudén; D. Vidal; A. Romero; M.T. Bordel; R. Rivera; J. Márquez; E. Zamora; L. Martinez; M.J. Ocaña; C. Vila; P. Iribarren; N. Corona; A. Zulaica;